Author Index

A

  • A, Eldesoky A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C [1.2, Issue 2, 2016, Pages 1-10]
  • A., Abdelgaleel Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
  • A., Ali Seroprevalence of hepatitis A virus infection in patients with chronic liver diseases: Do we need to vaccinate? [1.1, Issue 1, 2015, Pages 1-9]
  • A., Ali Liver histopathology detects more chronic hepatitis B virus genotype D patients who need to be treated [1.1, Issue 1, 2015, Pages 1-14]
  • A., Hasanain Seroprevalence of hepatitis A virus infection in patients with chronic liver diseases: Do we need to vaccinate? [1.1, Issue 1, 2015, Pages 1-9]
  • A., Helmy Evolution of treatment of chronic hepatitis C virus infection by directly acting anti-viral therapeutics: A glimmer of hope [1.1, Issue 1, 2015, Pages 1-11]
  • A., Helmy Seroprevalence of hepatitis A virus infection in patients with chronic liver diseases: Do we need to vaccinate? [1.1, Issue 1, 2015, Pages 1-9]
  • A., Helmy Liver histopathology detects more chronic hepatitis B virus genotype D patients who need to be treated [1.1, Issue 1, 2015, Pages 1-14]
  • A., Helmy Interferon-ë rs12979860CC genotype predicts sustained virological response to therapy in patients with chronic hepatitis C Genotype 4 but enhances hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-12]
  • A., Helmy Transient elastography (FibroScan) is not useful in the diagnosis of schistosomal hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-10]
  • A., Kamal Evolution of treatment of chronic hepatitis C virus infection by directly acting anti-viral therapeutics: A glimmer of hope [1.1, Issue 1, 2015, Pages 1-11]
  • A., Metwally A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C [1.2, Issue 2, 2016, Pages 1-10]
  • AA., El-Desoky Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
  • Abbas, Azza Hasan Burden of parasitic infection and its impact on growth of children with hepatitis C Virus [6.1, Issue 1, 2021, Pages 17-23]
  • Abbas, Azza Hasan Gaucher disease: Recent advances in the diagnosis and management. [6.2, Issue 2, 2022, Pages 6-10]
  • Abbas, Neven Assessment of muscle status and Sarcopenia in patients with liver cirrhosis [4.1, Issue 1, 2019, Pages 23-33]
  • Abbas, Neven Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 21-26]
  • Abbas, Neven Farouk Role of interferon gamma gene polymorphism in spontaneous viral clearance versus chronicity in hepatitis C infected Egyptian patients [6.1, Issue 1, 2021, Pages 24-31]
  • Abbas, Neven Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Abdalla, Abdelfattah Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]
  • Abdallah, Omar Serum fibroblast growth factor 19 and calcium channel α2δ1 subunit as diagnostic biomarkers for hepatocellular carcinoma [9.1, Issue 1, 2025, Pages 9-14]
  • Abdelaziz, Mohammed Non Hodgkin lymphoma of the cecum; case report [4.1, Issue 1, 2019, Pages 1-4]
  • Abdelaziz, Mohammed Infections in cirrhotic patients [4.1, Issue 1, 2019, Pages 5-14]
  • Abdelaziz, Mohammed Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Abdelaziz, Mohammed C-reactive protein to albumin ratio: A new score for predicting the recurrence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8.2, Issue 2, 2024, Pages 6-8]
  • Abdel Aziz, Rabee Evaluation of the causes and outcome of lower gastrointestinal bleeding: An endoscopic study [3.1, Issue 1, 2018, Pages 19-25]
  • Abd ElFattah, Fardous Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • Abdelhameid, Fatima A. Anti-cancer activity of hesperidin against hepatocellular carcinoma-induced in rats through upregulation of RIPK1 expression [7.1, Issue 1, 2022, Pages 15-20]
  • Abdelkader, Eman C-reactive protein to albumin ratio: A new score for predicting the recurrence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8.2, Issue 2, 2024, Pages 6-8]
  • Abdel khalek, Ahmed Multi-parametric magnetic resonance imaging as a diagnostic tool of hepatic steatosis for non-alcoholic fatty liver disease in Egyptian patients. [6.1, Issue 1, 2021, Pages 32-37]
  • Abdel-Khalek, Ehab Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Abd El-Magid, Ibrahim MicroRNA 122 as adiagnostic biomarker for hepatitis C- related hepatocellular carcinoma [4.1, Issue 1, 2019, Pages 35-43]
  • Abd-Elmaksood, Elsayed Outcomes of direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis [6.1, Issue 1, 2021, Pages 46-53]
  • Abd Elmaqsood, Sayed Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Abd Elmohsen, Eldesoky The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Abdelmoneim, Elhadidy Eosinophilic ascites: Uncommon Presentation of Eosinophilic Gastroenteritis in children [3.2, Issue 2, 2019, Pages 37-40]
  • Abdelmoneim, Elhadidy Cholestatic hepatitis in patient treated by carbimazole: A case report [4.2, Issue 2, 2020, Pages 53-55]
  • Abdelrahman, Mokhtar Nutritional status in cirrhosis; pathogenesis and management [3.2, Issue 2, 2019, Pages 41-47]
  • Abdelrazik, Ahmed Impact of COVID-19 on mortality rate in patients with chronic liver diseases, single-centre observational study [7.2, Issue 2, 2023, Pages 15-22]
  • Abdel-Razik, Ahmed Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Abdel-Razik, Ahmed Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Abdel-Razik, Ahmed Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Abdel-Razik, Ahmed Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
  • Abo El-khair, Salwa Pentraxin 3 level as a Biomarker for Diagnosis of Hepatitis C Virus Related Hepatocellular Carcinoma [8.2, Issue 2, 2024, Pages 1-7]
  • Aboud, Alaa Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt [4.1, Issue 1, 2019, Pages 45-52]
  • Abozeid, Fatma Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Abozeid, Fatma Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Adegboye, Oyaronbi Acute on chronic hepatic failure due to hepatitis B infection: A case report [5.3, Issue 3, 2021, Pages 27-31]
  • Adegboye, Oyaronbi ACUTE ON CHRONIC HEPATIC FAILURE DUE TO HEPATITS B INFECTION [(Articles in Press)]
  • Adel, Ibrahim Nutritional status in cirrhosis; pathogenesis and management [3.2, Issue 2, 2019, Pages 41-47]
  • Adetunji, Busayo Acute on chronic hepatic failure due to hepatitis B infection: A case report [5.3, Issue 3, 2021, Pages 27-31]
  • Adetunji, Busayo ACUTE ON CHRONIC HEPATIC FAILURE DUE TO HEPATITS B INFECTION [(Articles in Press)]
  • Aeriba, Mohammed Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • Afolabi, Samson Acute on chronic hepatic failure due to hepatitis B infection: A case report [5.3, Issue 3, 2021, Pages 27-31]
  • Afolabi, Samson ACUTE ON CHRONIC HEPATIC FAILURE DUE TO HEPATITS B INFECTION [(Articles in Press)]
  • Ahmed, Abdel-Razik The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B [3.2, Issue 2, 2019, Pages 57-64]
  • Ahmed, Abdel-Razik Spontaneous Bacterial Peritonitis: An Overview [3.1, Issue 1, 2018, Pages 13-17]
  • Ahmed, Abdel-Razik Periodontal disease as predictor of chronic liver diseases [4.2, Issue 2, 2020, Pages 57-61]
  • Ahmed, Alhawarey Management of chronic hepatitis B in special populations [4.2, Issue 2, 2020, Pages 63-68]
  • Ahmed, Deiab The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B [3.2, Issue 2, 2019, Pages 57-64]
  • Ahmed, El- Eraky Hepatorenal Syndrome: Update on pathogenesis and management [2.2, Issue 2, 2018, Pages 7-14]
  • Ahmed, El Shabrawi Alpha-Methyldopa-induced hepatitis during pregnancy [2.2, Issue 2, 2018, Pages 15-16]
  • Ahmed, El Shabrawi Periodontal disease as predictor of chronic liver diseases [4.2, Issue 2, 2020, Pages 57-61]
  • Ahmed, El Shahat Burden of parasitic infection and its impact on growth of children with hepatitis C Virus [6.1, Issue 1, 2021, Pages 17-23]
  • Ahmed, M. EL-Eraky Hepatopulmonary syndrome: A recent review of the literature [3.1, Issue 1, 2018, Pages 5-12]
  • Ahmed, Nancy Mini-dose albumin can reduce renal impairment in cirrhotic patients with spontaneous bacterial peritonitis [5.1, Issue 1, 2020, Pages 13-18]
  • Alaa, Habib Value of Cytokeratin-18 as a non-invasive diagnostic biomarker of nonalcoholic steatohepatitis (NASH) [3.2, Issue 2, 2019, Pages 65-74]
  • Alaa, Heba Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Alare, Kehinde Acute on chronic hepatic failure due to hepatitis B infection: A case report [5.3, Issue 3, 2021, Pages 27-31]
  • Alare, Kehinde ACUTE ON CHRONIC HEPATIC FAILURE DUE TO HEPATITS B INFECTION [(Articles in Press)]
  • Al Arman, Mohammed Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Al Ashgar, Hamad Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • Al Ashgar, Hamad Prevalence of Occult HCV Infections in Saudi Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Treatment [(Articles in Press)]
  • Albeltagy, Ahmed M. Evaluation of liver stiffness by non-invasive methods after eradication of HCV by direct-acting antiviral therapy: a retrospective observational study [6.3, Issue 3, 2022, Pages 5-11]
  • Aleraky, Shymaa Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Alhawarey, Ahmed Ibrahim The role of endoscopic ultrasound in patients with choledocholithiasis: A pilot study [4.2, Issue 2, 2020, Pages 81-86]
  • Alhawarey, Ahmed Ibrahim The Role of Endoscopic Ultrasound in Patients with Choledocholithiasis: A pilot study [(Articles in Press)]
  • Alhussaini, Hussa Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • Alhussaini, Hussa Prevalence of Occult HCV Infections in Saudi Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Treatment [(Articles in Press)]
  • Ali, Dina Mohammed Characterization of hepatocellular carcinoma in Mansoura university Hospitals: A case-control study of risk factors. [6.1, Issue 1, 2021, Pages 38-45]
  • Ali, Mohamed Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Ali, Sarah Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin. [5.2, Issue 2, 2021, Pages 32-39]
  • Al Kahtani, Khalid Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • Al Kahtani, Khalid Prevalence of Occult HCV Infections in Saudi Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Treatment [(Articles in Press)]
  • Alqahtani, Saleh A Prevalence of Occult HCV Infections in Saudi Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Treatment [(Articles in Press)]
  • Alqahtani, Saleh A Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • AlQahtani, Ahmed Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • AlQahtani, Ahmed Prevalence of Occult HCV Infections in Saudi Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Treatment [(Articles in Press)]
  • Al Quaiz, Consultant, Gastroenterologist Mohammed Prevalence of Occult HCV Infections in Saudi Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Treatment [(Articles in Press)]
  • Al Quaiz, Mohammed Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • Amany, Hasson Recent trends in chronic hepatitis C virus treatment [2.2, Issue 2, 2018, Pages 1-6]
  • Amany, Hasson Hepatopulmonary syndrome: A recent review of the literature [3.1, Issue 1, 2018, Pages 5-12]
  • Amekoudi, Yoan y. Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]
  • Amer, Amany A. Impact of long-term eradication of chronic Hepatitis C infection using the direct-acting antiviral treatment on liver fibrosis parameters in Egyptian patients [7.1, Issue 1, 2022, Pages 21-32]
  • Amer, Talaal Transient Elastography and its Correlation with Biochemical Scores in patients with Metabolic associated fatty liver disease [6.3, Issue 3, 2022, Pages 22-28]
  • Amer, Talaal Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
  • Amer, Talal Radiologic evaluation of nonalcoholic fatty liver Disease [6.1, Issue 1, 2021, Pages 10-16]
  • Amr, Samir Spontaneous Bacterial Peritonitis: An Overview [3.1, Issue 1, 2018, Pages 13-17]
  • Amr, Samir Periodontal disease as predictor of chronic liver diseases [4.2, Issue 2, 2020, Pages 57-61]
  • Anwar, Rokiah Mini-dose albumin can reduce renal impairment in cirrhotic patients with spontaneous bacterial peritonitis [5.1, Issue 1, 2020, Pages 13-18]
  • Anwar, Rokiah Management of chronic abdominal wall pain: A one-year study [5.1, Issue 1, 2020, Pages 33-40]
  • Anyovi, Folly Genetic Variability of NS5B Region of Hepatitis C Virus in Togo [5.3, Issue 3, 2021, Pages 8-13]
  • Anyovi, Folly Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]
  • Arafa, Mona Radiologic evaluation of nonalcoholic fatty liver Disease [6.1, Issue 1, 2021, Pages 10-16]
  • Arafa, Mona Multi-parametric magnetic resonance imaging as a diagnostic tool of hepatic steatosis for non-alcoholic fatty liver disease in Egyptian patients. [6.1, Issue 1, 2021, Pages 32-37]
  • Arafa, Mona Transient Elastography and its Correlation with Biochemical Scores in patients with Metabolic associated fatty liver disease [6.3, Issue 3, 2022, Pages 22-28]
  • Arafa, Mona Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
  • Arafa, Mona Impact of COVID-19 on mortality rate in patients with chronic liver diseases, single-centre observational study [7.2, Issue 2, 2023, Pages 15-22]
  • Arafa, Mona Pentraxin 3 level as a Biomarker for Diagnosis of Hepatitis C Virus Related Hepatocellular Carcinoma [8.2, Issue 2, 2024, Pages 1-7]
  • Askar, Marwa Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Ata, Lmyaa Impact of long-term eradication of chronic Hepatitis C infection using the direct-acting antiviral treatment on liver fibrosis parameters in Egyptian patients [7.1, Issue 1, 2022, Pages 21-32]
  • Atef, Elshazly The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B [3.2, Issue 2, 2019, Pages 57-64]
  • Attia, Attia Ahmed Screening of Occult Hepatitis B Virus Infection among Egyptian Blood Donors. [5.2, Issue 2, 2021, Pages 27-31]
  • Awad, Mahmoud Serum microRNA 106 and microRNA 223 as novel biomarkers in inflammatory bowel disease [5.1, Issue 1, 2020, Pages 19-24]
  • Awad, Mahmoud Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Awad, Mahmoud Outcomes of direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis [6.1, Issue 1, 2021, Pages 46-53]
  • Awad, Mahmoud M Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • Awad, Mahmoud Evaluation of liver stiffness by non-invasive methods after eradication of HCV by direct-acting antiviral therapy: a retrospective observational study [6.3, Issue 3, 2022, Pages 5-11]
  • Awad, Mahmoud Serum fibroblast growth factor 19 and calcium channel α2δ1 subunit as diagnostic biomarkers for hepatocellular carcinoma [9.1, Issue 1, 2025, Pages 9-14]

B

  • Badawy, Abd Elaziz The effect of melatonin on apoptosis in hepatocellular carcinoma cell line: An experimental study [3.2, Issue 2, 2019, Pages 75-79]
  • Bakr, Doaa Outcomes of direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis [6.1, Issue 1, 2021, Pages 46-53]
  • Balah, Emad Intracranial hemorrhage with COVID 19 patient; case report [5.1, Issue 1, 2020, Pages 3-5]
  • Bansal, Saurabh Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]
  • Beait, Khaled Mohamed The Endoscopic Ultrasound Evaluation of Pancreatic Cystic Lesions [8.1, Issue 1, 2024, Pages 23-28]
  • Besheer, Tarek Multi-parametric magnetic resonance imaging as a diagnostic tool of hepatic steatosis for non-alcoholic fatty liver disease in Egyptian patients. [6.1, Issue 1, 2021, Pages 32-37]
  • Bhatia, Shobna HCV Genotype 5a presenting with hepatocellular cancer: First report from India [5.1, Issue 1, 2020, Pages 1-2]

C

  • Chandnani, Sanjay Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]
  • Charles, Pardessus Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]
  • Chatterjee, Rupak Outcome of Hepatitis B treatment with oral drugs (Tenofovir and Entecavir) in a tertiary care center in eastern India [8.2, Issue 2, 2024, Pages 17-20]
  • Chevaliez, Stephane Genetic Variability of NS5B Region of Hepatitis C Virus in Togo [5.3, Issue 3, 2021, Pages 8-13]

D

  • Dalia, Moemen The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Dalia, Shaheen Value of Cytokeratin-18 as a non-invasive diagnostic biomarker of nonalcoholic steatohepatitis (NASH) [3.2, Issue 2, 2019, Pages 65-74]
  • Diasty, Muhammad Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Diasty, Muhammad Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Diasty, Muhammad Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]
  • Diasty, Muhammad Incidence and predictors of acute oesophageal variceal haemorrhage in patients with spontaneous bacterial peritonitis [7.1, Issue 1, 2022, Pages 1-7]
  • Diasty, Muhammad Predictors of 30-day hospital readmission in patients with spontaneous bacterial peritonitis, to improve health quality. Prospective cohort [7.3, Issue 3, 2023, Pages 7-14]
  • Dina, Elhammady Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy [4.2, Issue 2, 2020, Pages 69-73]
  • Dina, Nasr Frequency and characterization of mixed ascites among cirrhotic patients admitted to Zagazig University hospital [4.2, Issue 2, 2020, Pages 75-80]

E

  • E., Abd-Elkhalek Evolution of treatment of chronic hepatitis C virus infection by directly acting anti-viral therapeutics: A glimmer of hope [1.1, Issue 1, 2015, Pages 1-11]
  • E., Toson Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
  • EA., Ghoneem Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • Ehab, Ahmed Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 21-26]
  • Ehab, Ahmed Development of Focal segmental glomerulosclerosis 4- years following direct-acting antiviral therapy for hepatitis C virus infection: Case report [6.1, Issue 1, 2021, Pages 1-3]
  • Elabassy, Lamiaa Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Elabd, Naglaa S. Impact of long-term eradication of chronic Hepatitis C infection using the direct-acting antiviral treatment on liver fibrosis parameters in Egyptian patients [7.1, Issue 1, 2022, Pages 21-32]
  • Eladl, Ahmed Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]
  • Elalfy, Halem The Role of Endoscopic Ultrasound in Patients with Choledocholithiasis: A pilot study [(Articles in Press)]
  • Elalfy, Hatem Radiologic evaluation of nonalcoholic fatty liver Disease [6.1, Issue 1, 2021, Pages 10-16]
  • Elalfy, Hatem Transient Elastography and its Correlation with Biochemical Scores in patients with Metabolic associated fatty liver disease [6.3, Issue 3, 2022, Pages 22-28]
  • Elalfy, Hatem Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
  • Elbadrawy, Tasnim Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Elbaz El agroudy, Osama MicroRNA 122 as adiagnostic biomarker for hepatitis C- related hepatocellular carcinoma [4.1, Issue 1, 2019, Pages 35-43]
  • El-bendary, Mahmoud The Role of Endoscopic Ultrasound in Patients with Choledocholithiasis: A pilot study [(Articles in Press)]
  • El-Bendary, Mahmoud Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Eldars, Waleed Predictors of 30-day hospital readmission in patients with spontaneous bacterial peritonitis, to improve health quality. Prospective cohort [7.3, Issue 3, 2023, Pages 7-14]
  • El-Desoky, Abd- Elmohsen Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • ElDesoky, Abd ElMohsen Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • EL Ebidy, Gamal Characterization of hepatocellular carcinoma in Mansoura university Hospitals: A case-control study of risk factors. [6.1, Issue 1, 2021, Pages 38-45]
  • El-Emam, Ola Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]
  • El-Emam, Ola Diagnostic utility of absolute neutrophil count as a new marker of spontaneous bacterial peritonitis; multicenter study [6.3, Issue 3, 2022, Pages 12-18]
  • El-Emam, Ola Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • El-Eraky, Ahmed Mosaad Dynamic changes of systemic inflammatory markers and their association with radiologic progression and hepatotoxicity in patients with hepatocellular carcinoma on systemic therapy [9.1, Issue 1, 2025, Pages 1-7]
  • EL-Eraky, Ahmed M Radiologic evaluation of nonalcoholic fatty liver Disease [6.1, Issue 1, 2021, Pages 10-16]
  • EL-Eraky, Ahmed Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
  • Elfakhry, Ashraf Serum fibroblast growth factor 19 and calcium channel α2δ1 subunit as diagnostic biomarkers for hepatocellular carcinoma [9.1, Issue 1, 2025, Pages 9-14]
  • Elgamal, Ayman Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]
  • Elgamal, Salah Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Elghandou, Nereen Acute Epstein-Barr virus Encephalitis and hepatitis without mononucleosis syndrome: a case report [7.3, Issue 3, 2023, Pages 15-17]
  • El-gharabawy, Sahar Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis [5.2, Issue 2, 2021, Pages 16-20]
  • Elghnam, Ali Acute Epstein-Barr virus Encephalitis and hepatitis without mononucleosis syndrome: a case report [7.3, Issue 3, 2023, Pages 15-17]
  • Elhadidy, Abdelmoneim Intracranial hemorrhage with COVID 19 patient; case report [5.1, Issue 1, 2020, Pages 3-5]
  • Elhadidy, Abdelmoneim Development of Focal segmental glomerulosclerosis 4- years following direct-acting antiviral therapy for hepatitis C virus infection: Case report [6.1, Issue 1, 2021, Pages 1-3]
  • Elhadidy, Abdelmoneim Tertiary peritonitis in patients with cirrhotic ascites; Case report [6.3, Issue 3, 2022, Pages 29-31]
  • Elhadidy, Abdelmoneim Acute Epstein-Barr virus Encephalitis and hepatitis without mononucleosis syndrome: a case report [7.3, Issue 3, 2023, Pages 15-17]
  • Elhammady, Dina Role of interferon gamma gene polymorphism in spontaneous viral clearance versus chronicity in hepatitis C infected Egyptian patients [6.1, Issue 1, 2021, Pages 24-31]
  • Elhammady, Dina Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • ElHawary, Galal Platelet count/spleen diameter ratio as a predictor of high-risk esophageal varices in patients with liver cirrhosis [6.2, Issue 2, 2022, Pages 25-30]
  • Elhelaly, Rania Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis [5.2, Issue 2, 2021, Pages 16-20]
  • Elkady, Mostafa Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]
  • Elmahdi, Essam Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Elmahdi, Essam Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]
  • El-Mashad, Noha Mini-dose albumin can reduce renal impairment in cirrhotic patients with spontaneous bacterial peritonitis [5.1, Issue 1, 2020, Pages 13-18]
  • El-mesery, Ahmed Diagnostic utility of absolute neutrophil count as a new marker of spontaneous bacterial peritonitis; multicenter study [6.3, Issue 3, 2022, Pages 12-18]
  • El-mesery, Ahmed Incidence and predictors of acute oesophageal variceal haemorrhage in patients with spontaneous bacterial peritonitis [7.1, Issue 1, 2022, Pages 1-7]
  • El Mesery, Ahmed Pentraxin 3 level as a Biomarker for Diagnosis of Hepatitis C Virus Related Hepatocellular Carcinoma [8.2, Issue 2, 2024, Pages 1-7]
  • Elmetwalli, Alaa Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Elmetwalli, Alaa Screening of Occult Hepatitis B Virus Infection among Egyptian Blood Donors. [5.2, Issue 2, 2021, Pages 27-31]
  • Elmetwalli, Alaa Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Elmetwalli, Alaa The Impact of Energy Drinks on Liver Health [7.3, Issue 3, 2023, Pages 1-6]
  • Elmetwalli, Alaa C-reactive protein to albumin ratio: A new score for predicting the recurrence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8.2, Issue 2, 2024, Pages 6-8]
  • Elmoghazy, Mohammad Portal Hypertension, an Overview [4.1, Issue 1, 2019, Pages 15-21]
  • Elmoghazy, Mohammad Intracranial hemorrhage with COVID 19 patient; case report [5.1, Issue 1, 2020, Pages 3-5]
  • Elmoghazy, Mohammad Metabolic dysfunction-associated fatty liver disease from definition to complications [6.1, Issue 1, 2021, Pages 4-9]
  • Elnagdy, Fathy Tertiary peritonitis in patients with cirrhotic ascites; Case report [6.3, Issue 3, 2022, Pages 29-31]
  • Elnaggar, Mohamed Incidence and predictors of acute oesophageal variceal haemorrhage in patients with spontaneous bacterial peritonitis [7.1, Issue 1, 2022, Pages 1-7]
  • Elorbany, Abdelmoneim Acute Epstein-Barr virus Encephalitis and hepatitis without mononucleosis syndrome: a case report [7.3, Issue 3, 2023, Pages 15-17]
  • El-Saadany, Mohamed Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • El-Saadany, Mohammed The Endoscopic Ultrasound Evaluation of Pancreatic Cystic Lesions [8.1, Issue 1, 2024, Pages 23-28]
  • El-Sabbagh, Mohamed Impact of COVID-19 on mortality rate in patients with chronic liver diseases, single-centre observational study [7.2, Issue 2, 2023, Pages 15-22]
  • Elsaid, Abeer Mini-dose albumin can reduce renal impairment in cirrhotic patients with spontaneous bacterial peritonitis [5.1, Issue 1, 2020, Pages 13-18]
  • Elsaid, Elbadrawy Management of chronic hepatitis B in special populations [4.2, Issue 2, 2020, Pages 63-68]
  • Elsaid, Elbadrawy Frequency and characterization of mixed ascites among cirrhotic patients admitted to Zagazig University hospital [4.2, Issue 2, 2020, Pages 75-80]
  • EL-Sakka, Sama A. Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • El-sayed, Ahmed Impact of COVID-19 on mortality rate in patients with chronic liver diseases, single-centre observational study [7.2, Issue 2, 2023, Pages 15-22]
  • El-Sayed Shiha, Gamal MicroRNA 122 as adiagnostic biomarker for hepatitis C- related hepatocellular carcinoma [4.1, Issue 1, 2019, Pages 35-43]
  • Elsebaie, Ahmed Influence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease [5.1, Issue 1, 2020, Pages 25-32]
  • Elsebaie, Ahmed Hassan Influence of Liraglutide, Dulaglutide Versus Conventional Treatment on Fatty liver index and Fibrosis-4 Score in Egyptian Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. [(Articles in Press)]
  • El Shabrawi, Ahmed Non Hodgkin lymphoma of the cecum; case report [4.1, Issue 1, 2019, Pages 1-4]
  • El Shabrawi, Ahmed Infections in cirrhotic patients [4.1, Issue 1, 2019, Pages 5-14]
  • El Shabrawi, Ahmed Portal Hypertension, an Overview [4.1, Issue 1, 2019, Pages 15-21]
  • Elsherbiny, Hend Predictors of 30-day hospital readmission in patients with spontaneous bacterial peritonitis, to improve health quality. Prospective cohort [7.3, Issue 3, 2023, Pages 7-14]
  • Elsherbiny, Samir Tertiary peritonitis in patients with cirrhotic ascites; Case report [6.3, Issue 3, 2022, Pages 29-31]
  • El-Shishtawy, Mamdouh M. Anti-cancer activity of hesperidin against hepatocellular carcinoma-induced in rats through upregulation of RIPK1 expression [7.1, Issue 1, 2022, Pages 15-20]
  • Elssadany, Amr M Prevalence of Occult HCV Infections in Saudi Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Treatment [(Articles in Press)]
  • Elssadany, Amr M Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • Eltayeb, M. Fikry Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • El-Wakeel, Niveen Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • El-Wakeel, Niveen Diagnostic utility of absolute neutrophil count as a new marker of spontaneous bacterial peritonitis; multicenter study [6.3, Issue 3, 2022, Pages 12-18]
  • Elzaafarany, Maha Characterization of hepatocellular carcinoma in Mansoura university Hospitals: A case-control study of risk factors. [6.1, Issue 1, 2021, Pages 38-45]
  • Eman, Mousa Periodontal disease as predictor of chronic liver diseases [4.2, Issue 2, 2020, Pages 57-61]
  • Eman, Mousa Management of chronic hepatitis B in special populations [4.2, Issue 2, 2020, Pages 63-68]
  • Esmat, Mohammed Value of Cytokeratin-18 as a non-invasive diagnostic biomarker of nonalcoholic steatohepatitis (NASH) [3.2, Issue 2, 2019, Pages 65-74]
  • Essa, Abdallah Serum microRNA 106 and microRNA 223 as novel biomarkers in inflammatory bowel disease [5.1, Issue 1, 2020, Pages 19-24]
  • Essa, Abdallah Evaluation of liver stiffness by non-invasive methods after eradication of HCV by direct-acting antiviral therapy: a retrospective observational study [6.3, Issue 3, 2022, Pages 5-11]
  • Ezzat, Ahmed Metabolic dysfunction-associated fatty liver disease from definition to complications [6.1, Issue 1, 2021, Pages 4-9]

F

  • F., Ahmed Demographics of incidentally diagnosed chronic hepatitis B in teenagers in Bangladesh [1.1, Issue 1, 2015, Pages 1-9]
  • F., Karim Demographics of incidentally diagnosed chronic hepatitis B in teenagers in Bangladesh [1.1, Issue 1, 2015, Pages 1-9]
  • Farag, Raghda Radiologic evaluation of nonalcoholic fatty liver Disease [6.1, Issue 1, 2021, Pages 10-16]
  • Farag, Raghda Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
  • Farha, Elshinawy The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B [3.2, Issue 2, 2019, Pages 57-64]
  • Farid, Khaled Dynamic changes of systemic inflammatory markers and their association with radiologic progression and hepatotoxicity in patients with hepatocellular carcinoma on systemic therapy [9.1, Issue 1, 2025, Pages 1-7]
  • Fathiya, El-Raey Simple-type Caroli disease with diffuse involvement of the liver: A case report [3.1, Issue 1, 2018, Pages 1-4]
  • Fathy, Aya Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Fathy, Aya Ahmed Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]

G

  • G., Shiha Seroprevalence of hepatitis A virus infection in patients with chronic liver diseases: Do we need to vaccinate? [1.1, Issue 1, 2015, Pages 1-9]
  • G., Shiha Liver histopathology detects more chronic hepatitis B virus genotype D patients who need to be treated [1.1, Issue 1, 2015, Pages 1-14]
  • G., Shiha Interferon-ë rs12979860CC genotype predicts sustained virological response to therapy in patients with chronic hepatitis C Genotype 4 but enhances hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-12]
  • G., Shiha A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C [1.2, Issue 2, 2016, Pages 1-10]
  • G., Shiha Transient elastography (FibroScan) is not useful in the diagnosis of schistosomal hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-10]
  • G., Shiha Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
  • G., Shiha The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study [2.1, Issue 1, 2016, Pages 1-8]
  • G., Shiha Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • G., Shiha Fibrogenic/Angiogenic Linker for Non-invasive assessment of hepatic fibrosis staging in chronic hepatitis C genotype 4 patients [2.1, Issue 1, 2016, Pages 1-14]
  • G., Shiha Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
  • Gad, Marwa Assessment of muscle status and Sarcopenia in patients with liver cirrhosis [4.1, Issue 1, 2019, Pages 23-33]
  • Galal, Ahmed Characterization of hepatocellular carcinoma in Mansoura university Hospitals: A case-control study of risk factors. [6.1, Issue 1, 2021, Pages 38-45]
  • Gamal, Shiha Noninvasive markers for staging fibrosis in chronic hepatitis B patients [2.2, Issue 2, 2018, Pages 17-23]
  • Gamal, Shiha Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]
  • Gamal, Soliman The role of endoscopic ultrasound in patients with choledocholithiasis: A pilot study [4.2, Issue 2, 2020, Pages 81-86]
  • Ghadeer, Mosaad The effect of melatonin on apoptosis in hepatocellular carcinoma cell line: An experimental study [3.2, Issue 2, 2019, Pages 75-79]
  • Ghoneem, Elsayed The Endoscopic Ultrasound Evaluation of Pancreatic Cystic Lesions [8.1, Issue 1, 2024, Pages 23-28]
  • Greco, Sonia Fulminant hepatitis by concurrent acute HBV-HCV infection successfully treated with antivirals while seeking for an orthotopic liver transplantation [7.1, Issue 1, 2022, Pages 13-14]

H

  • H., Mikhail The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study [2.1, Issue 1, 2016, Pages 1-8]
  • Habeeb, Maha R. Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis [5.2, Issue 2, 2021, Pages 16-20]
  • Habeeb, Maha R Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin. [5.2, Issue 2, 2021, Pages 32-39]
  • Habeeb, Maha R Predictors of early re-bleeding and mortality in patients with first attack of gastric variceal hemorrhage [5.3, Issue 3, 2021, Pages 14-21]
  • Habeeb, Maha R Role of interferon gamma gene polymorphism in spontaneous viral clearance versus chronicity in hepatitis C infected Egyptian patients [6.1, Issue 1, 2021, Pages 24-31]
  • Habeeb, Maha Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Habeeb, Maha The Endoscopic Ultrasound Evaluation of Pancreatic Cystic Lesions [8.1, Issue 1, 2024, Pages 23-28]
  • Habib, Alaa Serum microRNA 106 and microRNA 223 as novel biomarkers in inflammatory bowel disease [5.1, Issue 1, 2020, Pages 19-24]
  • Habib, Alaa Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Habib, Alaa Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Habib, Alaaudin Evaluation of liver stiffness by non-invasive methods after eradication of HCV by direct-acting antiviral therapy: a retrospective observational study [6.3, Issue 3, 2022, Pages 5-11]
  • Habib, Alaaudin Diagnostic utility of absolute neutrophil count as a new marker of spontaneous bacterial peritonitis; multicenter study [6.3, Issue 3, 2022, Pages 12-18]
  • Habl, Mohamed Management of chronic abdominal wall pain: A one-year study [5.1, Issue 1, 2020, Pages 33-40]
  • Hakim Elmenshawy, Hazem MicroRNA 122 as adiagnostic biomarker for hepatitis C- related hepatocellular carcinoma [4.1, Issue 1, 2019, Pages 35-43]
  • Hamdy, Ghada The Impact of Energy Drinks on Liver Health [7.3, Issue 3, 2023, Pages 1-6]
  • Hanaa, El-Said Frequency and characterization of mixed ascites among cirrhotic patients admitted to Zagazig University hospital [4.2, Issue 2, 2020, Pages 75-80]
  • Hassan, Ayman A. The Impact of Energy Drinks on Liver Health [7.3, Issue 3, 2023, Pages 1-6]
  • Hassan, Elbatae Periodontal disease as predictor of chronic liver diseases [4.2, Issue 2, 2020, Pages 57-61]
  • Hassan, Ibrahim Outcomes of direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis [6.1, Issue 1, 2021, Pages 46-53]
  • Hassan, Jihan Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Hassan, Jihan The Impact of Energy Drinks on Liver Health [7.3, Issue 3, 2023, Pages 1-6]
  • Hassan, Jihan C-reactive protein to albumin ratio: A new score for predicting the recurrence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8.2, Issue 2, 2024, Pages 6-8]
  • Hassan, Mervat G. Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Hassan, Rashd Is there is a link between oral microbiome and chronic liver diseases [6.3, Issue 3, 2022, Pages 19-21]
  • Hassan, Riham Dynamic changes of systemic inflammatory markers and their association with radiologic progression and hepatotoxicity in patients with hepatocellular carcinoma on systemic therapy [9.1, Issue 1, 2025, Pages 1-7]
  • Hassan, Rizk The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B [3.2, Issue 2, 2019, Pages 57-64]
  • Hassanin, Fetouh Burden of parasitic infection and its impact on growth of children with hepatitis C Virus [6.1, Issue 1, 2021, Pages 17-23]
  • Hassanin, Fetouh Gaucher disease: Recent advances in the diagnosis and management. [6.2, Issue 2, 2022, Pages 6-10]
  • Hasson, Amany Multi-parametric magnetic resonance imaging as a diagnostic tool of hepatic steatosis for non-alcoholic fatty liver disease in Egyptian patients. [6.1, Issue 1, 2021, Pages 32-37]
  • Hasson, Amany Dynamic changes of systemic inflammatory markers and their association with radiologic progression and hepatotoxicity in patients with hepatocellular carcinoma on systemic therapy [9.1, Issue 1, 2025, Pages 1-7]
  • Hatem, Elalfy The role of endoscopic ultrasound in patients with choledocholithiasis: A pilot study [4.2, Issue 2, 2020, Pages 81-86]
  • Heba, Elkareem The effect of melatonin on apoptosis in hepatocellular carcinoma cell line: An experimental study [3.2, Issue 2, 2019, Pages 75-79]
  • Hoda, Elgamal Hepatorenal Syndrome: Update on pathogenesis and management [2.2, Issue 2, 2018, Pages 7-14]
  • Hoda, Elgamal Spontaneous Bacterial Peritonitis: An Overview [3.1, Issue 1, 2018, Pages 13-17]
  • Hoda, Elgamal Management of chronic hepatitis B in special populations [4.2, Issue 2, 2020, Pages 63-68]
  • Hosni, Khaled Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Hussein, Okasha The role of endoscopic ultrasound in patients with choledocholithiasis: A pilot study [4.2, Issue 2, 2020, Pages 81-86]

I

  • Ibrahem, Maha Characterization of hepatocellular carcinoma in Mansoura university Hospitals: A case-control study of risk factors. [6.1, Issue 1, 2021, Pages 38-45]
  • Ibrahem, Maha Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]
  • Ibrahim, Adel Assessment of muscle status and Sarcopenia in patients with liver cirrhosis [4.1, Issue 1, 2019, Pages 23-33]
  • Ibrahim, Amani M Predictors of early re-bleeding and mortality in patients with first attack of gastric variceal hemorrhage [5.3, Issue 3, 2021, Pages 14-21]
  • Ibrahim, Ibrahim Frequency and characterization of mixed ascites among cirrhotic patients admitted to Zagazig University hospital [4.2, Issue 2, 2020, Pages 75-80]
  • Ilham, Talat qattan The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B [3.2, Issue 2, 2019, Pages 57-64]
  • Islam, Mohamed Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy [4.2, Issue 2, 2020, Pages 69-73]
  • Ismail, Mohamed Serum fibroblast growth factor 19 and calcium channel α2δ1 subunit as diagnostic biomarkers for hepatocellular carcinoma [9.1, Issue 1, 2025, Pages 9-14]
  • Ismail, Nadia F. The Impact of Energy Drinks on Liver Health [7.3, Issue 3, 2023, Pages 1-6]
  • Ismail, Nadia C-reactive protein to albumin ratio: A new score for predicting the recurrence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8.2, Issue 2, 2024, Pages 6-8]

J

  • Jain, Shubham Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]
  • Jena, Anuraag Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]

K

  • K., Zalata Interferon-ë rs12979860CC genotype predicts sustained virological response to therapy in patients with chronic hepatitis C Genotype 4 but enhances hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-12]
  • K., Zalata A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C [1.2, Issue 2, 2016, Pages 1-10]
  • K., Zalata Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • Kalil, Elsayed A. Predictors of early re-bleeding and mortality in patients with first attack of gastric variceal hemorrhage [5.3, Issue 3, 2021, Pages 14-21]
  • Karou, Simplice D. Genetic Variability of NS5B Region of Hepatitis C Virus in Togo [5.3, Issue 3, 2021, Pages 8-13]
  • Karou, Simplice Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]
  • Khaled, Farid Eosinophilic ascites: Uncommon Presentation of Eosinophilic Gastroenteritis in children [3.2, Issue 2, 2019, Pages 37-40]
  • Khaled, Farid Simple-type Caroli disease with diffuse involvement of the liver: A case report [3.1, Issue 1, 2018, Pages 1-4]
  • Khalifa, Amany Serum microRNA 106 and microRNA 223 as novel biomarkers in inflammatory bowel disease [5.1, Issue 1, 2020, Pages 19-24]

M

  • M, Elbasiony Transient elastography (FibroScan) is not useful in the diagnosis of schistosomal hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-10]
  • M, El Sherbini Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • M., Al-Mahtab Demographics of incidentally diagnosed chronic hepatitis B in teenagers in Bangladesh [1.1, Issue 1, 2015, Pages 1-9]
  • M., Bahgat Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • M., Elbasiony Liver histopathology detects more chronic hepatitis B virus genotype D patients who need to be treated [1.1, Issue 1, 2015, Pages 1-14]
  • M., Elbasiony A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C [1.2, Issue 2, 2016, Pages 1-10]
  • M., Elbasiony Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
  • M., El-Basiouny Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
  • M., El-Basiouny The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study [2.1, Issue 1, 2016, Pages 1-8]
  • M., El-Basiouny Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • M., Hamed Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • M., Jalil Demographics of incidentally diagnosed chronic hepatitis B in teenagers in Bangladesh [1.1, Issue 1, 2015, Pages 1-9]
  • Maha, M. Maher Evaluation of the causes and outcome of lower gastrointestinal bleeding: An endoscopic study [3.1, Issue 1, 2018, Pages 19-25]
  • Maher, Rania Development of Focal segmental glomerulosclerosis 4- years following direct-acting antiviral therapy for hepatitis C virus infection: Case report [6.1, Issue 1, 2021, Pages 1-3]
  • Mahmoud, Abdel-Aziz Recent trends in chronic hepatitis C virus treatment [2.2, Issue 2, 2018, Pages 1-6]
  • Mahmoud, Abdel-Aziz Alpha-Methyldopa-induced hepatitis during pregnancy [2.2, Issue 2, 2018, Pages 15-16]
  • Mahmoud, Alaa N Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis [5.2, Issue 2, 2021, Pages 16-20]
  • Mahmoud, awad Nutritional status in cirrhosis; pathogenesis and management [3.2, Issue 2, 2019, Pages 41-47]
  • Mahmoud, Awad Value of Cytokeratin-18 as a non-invasive diagnostic biomarker of nonalcoholic steatohepatitis (NASH) [3.2, Issue 2, 2019, Pages 65-74]
  • Mahmoud, Awad Hepatorenal Syndrome: Update on pathogenesis and management [2.2, Issue 2, 2018, Pages 7-14]
  • Mahmoud, Awad The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Mahmoud, Awad Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy [4.2, Issue 2, 2020, Pages 69-73]
  • Mahmoud, El-bendary The role of endoscopic ultrasound in patients with choledocholithiasis: A pilot study [4.2, Issue 2, 2020, Pages 81-86]
  • Mahmoud, Rasha Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Mahmoud Khalil, Doaa Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt [4.1, Issue 1, 2019, Pages 45-52]
  • Makharita, Mohamed Management of chronic abdominal wall pain: A one-year study [5.1, Issue 1, 2020, Pages 33-40]
  • Mandal, Madhuchhanda Outcome of Hepatitis B treatment with oral drugs (Tenofovir and Entecavir) in a tertiary care center in eastern India [8.2, Issue 2, 2024, Pages 17-20]
  • Manfredi, Roberto Fulminant hepatitis by concurrent acute HBV-HCV infection successfully treated with antivirals while seeking for an orthotopic liver transplantation [7.1, Issue 1, 2022, Pages 13-14]
  • Marwa, Alfar B-cell monoclonal lymphocytosis in chronic hepatitis C virus infection [3.1, Issue 1, 2018, Pages 27-35]
  • Marzouk, Rehab Influence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease [5.1, Issue 1, 2020, Pages 25-32]
  • Marzouk, Rehab Elsayed Influence of Liraglutide, Dulaglutide Versus Conventional Treatment on Fatty liver index and Fibrosis-4 Score in Egyptian Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. [(Articles in Press)]
  • Mastroianni, Antonio Fulminant hepatitis by concurrent acute HBV-HCV infection successfully treated with antivirals while seeking for an orthotopic liver transplantation [7.1, Issue 1, 2022, Pages 13-14]
  • Mauro, Maria Vittoria Fulminant hepatitis by concurrent acute HBV-HCV infection successfully treated with antivirals while seeking for an orthotopic liver transplantation [7.1, Issue 1, 2022, Pages 13-14]
  • Menessy, Ayman Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Menesy, Ayman Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 21-26]
  • Metwally, AM Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program [7.2, Issue 2, 2023, Pages 9-14]
  • Mikhail, NNH Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program [7.2, Issue 2, 2023, Pages 9-14]
  • Minisi, Ayman Serum microRNA 106 and microRNA 223 as novel biomarkers in inflammatory bowel disease [5.1, Issue 1, 2020, Pages 19-24]
  • Mohamed, Abdelaziz Hepatitis B Virus: Update in Management [3.2, Issue 2, 2019, Pages 49-56]
  • Mohamed, Abdel-Aziz Management of chronic hepatitis B in special populations [4.2, Issue 2, 2020, Pages 63-68]
  • Mohamed, Abdelhamed Hepatitis B Virus: Update in Management [3.2, Issue 2, 2019, Pages 49-56]
  • Mohamed, Abd El- Maksoud B-cell monoclonal lymphocytosis in chronic hepatitis C virus infection [3.1, Issue 1, 2018, Pages 27-35]
  • Mohamed, Abd EL Maksoud The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Mohamed, Farag Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin. [5.2, Issue 2, 2021, Pages 32-39]
  • Mohamed, Salah Noninvasive markers for staging fibrosis in chronic hepatitis B patients [2.2, Issue 2, 2018, Pages 17-23]
  • Mohamed, Sherin C-reactive protein to albumin ratio: A new score for predicting the recurrence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8.2, Issue 2, 2024, Pages 6-8]
  • Mohammad, Elmoghazy Simple-type Caroli disease with diffuse involvement of the liver: A case report [3.1, Issue 1, 2018, Pages 1-4]
  • Mohsen, Mohammed Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Mokhtar, Abdelrahman Assessment of muscle status and Sarcopenia in patients with liver cirrhosis [4.1, Issue 1, 2019, Pages 23-33]
  • Mokhtar, Abdel Rahman Management of chronic abdominal wall pain: A one-year study [5.1, Issue 1, 2020, Pages 33-40]
  • Mokhtar, Abdel-Rahman Mini-dose albumin can reduce renal impairment in cirrhotic patients with spontaneous bacterial peritonitis [5.1, Issue 1, 2020, Pages 13-18]
  • Mona, Arafa Hepatopulmonary syndrome: A recent review of the literature [3.1, Issue 1, 2018, Pages 5-12]
  • Mosaad, Ahmed Transient Elastography and its Correlation with Biochemical Scores in patients with Metabolic associated fatty liver disease [6.3, Issue 3, 2022, Pages 22-28]
  • Mostafa, Elshenaway Periodontal disease as predictor of chronic liver diseases [4.2, Issue 2, 2020, Pages 57-61]
  • Mostafa, Elshenaway Management of chronic hepatitis B in special populations [4.2, Issue 2, 2020, Pages 63-68]
  • Mostafa, Sally Abdallah Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Mousa, Aya Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Mousa, Aya Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Mousa, Eman Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Mousa, Eman Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Mousa, Eman Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Mousa, Eman Is there is a link between oral microbiome and chronic liver diseases [6.3, Issue 3, 2022, Pages 19-21]
  • Mousa, Eman Incidence and predictors of acute oesophageal variceal haemorrhage in patients with spontaneous bacterial peritonitis [7.1, Issue 1, 2022, Pages 1-7]
  • Mousa, Eman Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Mousa, Nasser Non Hodgkin lymphoma of the cecum; case report [4.1, Issue 1, 2019, Pages 1-4]
  • Mousa, Nasser Infections in cirrhotic patients [4.1, Issue 1, 2019, Pages 5-14]
  • Mousa, Nasser Portal Hypertension, an Overview [4.1, Issue 1, 2019, Pages 15-21]
  • Mousa, Nasser Intracranial hemorrhage with COVID 19 patient; case report [5.1, Issue 1, 2020, Pages 3-5]
  • Mousa, Nasser Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Mousa, Nasser Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Mousa, Nasser Value of hepatic artery resistive index in evaluation of liver fibrosis related to non-alcoholic fatty liver diseases [7.2, Issue 2, 2023, Pages 1-8]
  • Muhammad, Diasty Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy [4.2, Issue 2, 2020, Pages 69-73]
  • Mukherjee, Shatavisa Outcome of Hepatitis B treatment with oral drugs (Tenofovir and Entecavir) in a tertiary care center in eastern India [8.2, Issue 2, 2024, Pages 17-20]

N

  • N, Ahmed Transient elastography (FibroScan) is not useful in the diagnosis of schistosomal hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-10]
  • Nabiel, Mikhail Noninvasive markers for staging fibrosis in chronic hepatitis B patients [2.2, Issue 2, 2018, Pages 17-23]
  • Nabiel, Mikhail The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Nada, Ali Impact of long-term eradication of chronic Hepatitis C infection using the direct-acting antiviral treatment on liver fibrosis parameters in Egyptian patients [7.1, Issue 1, 2022, Pages 21-32]
  • Nahas, Mohamed Serum fibroblast growth factor 19 and calcium channel α2δ1 subunit as diagnostic biomarkers for hepatocellular carcinoma [9.1, Issue 1, 2025, Pages 9-14]
  • Narmin, Effat The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Nasser, Mousa Nutritional status in cirrhosis; pathogenesis and management [3.2, Issue 2, 2019, Pages 41-47]
  • Nasser, Mousa Hepatitis B Virus: Update in Management [3.2, Issue 2, 2019, Pages 49-56]
  • Nasser, Mousa The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B [3.2, Issue 2, 2019, Pages 57-64]
  • Nasser, Mousa Recent trends in chronic hepatitis C virus treatment [2.2, Issue 2, 2018, Pages 1-6]
  • Nasser, Mousa Hepatorenal Syndrome: Update on pathogenesis and management [2.2, Issue 2, 2018, Pages 7-14]
  • Nasser, Mousa Alpha-Methyldopa-induced hepatitis during pregnancy [2.2, Issue 2, 2018, Pages 15-16]
  • Nasser, Mousa Noninvasive markers for staging fibrosis in chronic hepatitis B patients [2.2, Issue 2, 2018, Pages 17-23]
  • Nasser, Mousa The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Nasser, Mousa Simple-type Caroli disease with diffuse involvement of the liver: A case report [3.1, Issue 1, 2018, Pages 1-4]
  • Nasser, Mousa B-cell monoclonal lymphocytosis in chronic hepatitis C virus infection [3.1, Issue 1, 2018, Pages 27-35]
  • Nasser, Mousa Periodontal disease as predictor of chronic liver diseases [4.2, Issue 2, 2020, Pages 57-61]
  • Nasser, Mousa Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy [4.2, Issue 2, 2020, Pages 69-73]
  • Nawghare, Pankaj Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]
  • Neven, Abbas Nutritional status in cirrhosis; pathogenesis and management [3.2, Issue 2, 2019, Pages 41-47]
  • NF., Abbas Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
  • Niveen, El-Wakeel The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • NNH., Mikhail Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
  • NNH., Mikhail Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]

O

  • Okasha, Hussein The Role of Endoscopic Ultrasound in Patients with Choledocholithiasis: A pilot study [(Articles in Press)]
  • Olajire, Akinbode Acute on chronic hepatic failure due to hepatitis B infection: A case report [5.3, Issue 3, 2021, Pages 27-31]
  • Olajire, Akinbode ACUTE ON CHRONIC HEPATIC FAILURE DUE TO HEPATITS B INFECTION [(Articles in Press)]
  • Omar, Ashraf Outcomes of direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis [6.1, Issue 1, 2021, Pages 46-53]
  • Omar, Maha Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]

P

  • Patel, Aishwarya Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]
  • Patel, Sameet Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]
  • Pawar, Chandrakant Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]
  • PEEDIKAYIL, MUSTHAFA Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment [5.1, Issue 1, 2020, Pages 7-12]
  • PEEDIKAYIL, MUSTHAFA C Prevalence of Occult HCV Infections in Saudi Patients who Achieved Sustained Virologic Response with Direct Acting Antiviral Treatment [(Articles in Press)]
  • Poiteau, Lila Genetic Variability of NS5B Region of Hepatitis C Virus in Togo [5.3, Issue 3, 2021, Pages 8-13]
  • Pramanik, Netai Outcome of Hepatitis B treatment with oral drugs (Tenofovir and Entecavir) in a tertiary care center in eastern India [8.2, Issue 2, 2024, Pages 17-20]

R

  • R., Soliman Seroprevalence of hepatitis A virus infection in patients with chronic liver diseases: Do we need to vaccinate? [1.1, Issue 1, 2015, Pages 1-9]
  • R., Soliman Interferon-ë rs12979860CC genotype predicts sustained virological response to therapy in patients with chronic hepatitis C Genotype 4 but enhances hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-12]
  • R., Soliman A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C [1.2, Issue 2, 2016, Pages 1-10]
  • R., Soliman Transient elastography (FibroScan) is not useful in the diagnosis of schistosomal hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-10]
  • R., Soliman Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience [2.1, Issue 1, 2016, Pages 1-8]
  • R., Soliman The 13C-Aminopyrine Breath Test Predicts Advanced Fibrosis in Patients with Chronic Hepatitis C: A Pilot Study [2.1, Issue 1, 2016, Pages 1-8]
  • R., Soliman Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • Raba, Mohamed Burden of parasitic infection and its impact on growth of children with hepatitis C Virus [6.1, Issue 1, 2021, Pages 17-23]
  • Rabea, Mohamed Gaucher disease: Recent advances in the diagnosis and management. [6.2, Issue 2, 2022, Pages 6-10]
  • Raghda, Farag Recent trends in chronic hepatitis C virus treatment [2.2, Issue 2, 2018, Pages 1-6]
  • Raj, Rishi Metabolic Associated Fatty Liver Disease as the New Nomenclature for Nonalcoholic Fatty Liver Disease [6.2, Issue 2, 2022, Pages 4-5]
  • Ramadan, Ahmed Characterization of hepatocellular carcinoma in Mansoura university Hospitals: A case-control study of risk factors. [6.1, Issue 1, 2021, Pages 38-45]
  • Ramadan, Ahmed Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]
  • Rathi, Pravin Predictors of mortality in a large cohort of patients with acute hepatitis in a Low Middle-Income Country [8.2, Issue 2, 2024, Pages 9-10]
  • Reda, Elbadawy The effect of melatonin on apoptosis in hepatocellular carcinoma cell line: An experimental study [3.2, Issue 2, 2019, Pages 75-79]
  • Reda, El Badawy Hepatitis B Virus: Update in Management [3.2, Issue 2, 2019, Pages 49-56]
  • Reham, Soliman Recent trends in chronic hepatitis C virus treatment [2.2, Issue 2, 2018, Pages 1-6]
  • Reham, Soliman Hepatorenal Syndrome: Update on pathogenesis and management [2.2, Issue 2, 2018, Pages 7-14]
  • Reham, Soliman Alpha-Methyldopa-induced hepatitis during pregnancy [2.2, Issue 2, 2018, Pages 15-16]
  • Reham, Soliman Noninvasive markers for staging fibrosis in chronic hepatitis B patients [2.2, Issue 2, 2018, Pages 17-23]
  • Rizk, Rania C-reactive protein to albumin ratio: A new score for predicting the recurrence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8.2, Issue 2, 2024, Pages 6-8]
  • Roshdy, Noha Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]
  • Rozaik, Salah Eldeen Influence of liraglutide, dulaglutide versus conventional treatment on fatty liver index and fibrosis-4 score in Egyptian patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease [5.1, Issue 1, 2020, Pages 25-32]
  • Rozik, Salah eldeen Influence of Liraglutide, Dulaglutide Versus Conventional Treatment on Fatty liver index and Fibrosis-4 Score in Egyptian Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease. [(Articles in Press)]

S

  • S., El-Etreby Comparison between Transient Elastography (FibroScan) and Liver Biopsy for the Diagnosis of Hepatic Fibrosis in Chronic Hepatitis C Patients [2.1, Issue 1, 2016, Pages 1-9]
  • S., Rahman Demographics of incidentally diagnosed chronic hepatitis B in teenagers in Bangladesh [1.1, Issue 1, 2015, Pages 1-9]
  • S., Seif Interferon-ë rs12979860CC genotype predicts sustained virological response to therapy in patients with chronic hepatitis C Genotype 4 but enhances hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-12]
  • S., Seif A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C [1.2, Issue 2, 2016, Pages 1-10]
  • Saad, Rokia Anwar Role of interferon gamma gene polymorphism in spontaneous viral clearance versus chronicity in hepatitis C infected Egyptian patients [6.1, Issue 1, 2021, Pages 24-31]
  • Sabi, Akomola k. Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]
  • Sabry, Mohammed Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 9-15]
  • Saed, Ahmed Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 9-15]
  • Sahar, Zakaria The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Saied, Narmin Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Saif, Maha Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Saif Elnaser, Mounir Mortality risk and associated factors in cirrhosis patients with SARS-CoV-2 infection [8.1, Issue 1, 2024, Pages 9-16]
  • Salah, Mohamed Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Salah, Mohamed The Impact of Energy Drinks on Liver Health [7.3, Issue 3, 2023, Pages 1-6]
  • Salama, Heba C-reactive protein to albumin ratio: A new score for predicting the recurrence of spontaneous bacterial peritonitis in cirrhotic patients with ascites [8.2, Issue 2, 2024, Pages 6-8]
  • Salama, Kamal Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Salama, Kamal Diagnostic utility of absolute neutrophil count as a new marker of spontaneous bacterial peritonitis; multicenter study [6.3, Issue 3, 2022, Pages 12-18]
  • Salama Sieddek, Asmaa Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt [4.1, Issue 1, 2019, Pages 45-52]
  • Sally, abed Recent trends in chronic hepatitis C virus treatment [2.2, Issue 2, 2018, Pages 1-6]
  • Sally, Abed Noninvasive markers for staging fibrosis in chronic hepatitis B patients [2.2, Issue 2, 2018, Pages 17-23]
  • Sameh, Abdel Monem Periodontal disease as predictor of chronic liver diseases [4.2, Issue 2, 2020, Pages 57-61]
  • Sameh, Abdel Monem Frequency and characterization of mixed ascites among cirrhotic patients admitted to Zagazig University hospital [4.2, Issue 2, 2020, Pages 75-80]
  • Samir, Mahmoud Pentraxin 3 level as a Biomarker for Diagnosis of Hepatitis C Virus Related Hepatocellular Carcinoma [8.2, Issue 2, 2024, Pages 1-7]
  • Samra, Yara A. Anti-cancer activity of hesperidin against hepatocellular carcinoma-induced in rats through upregulation of RIPK1 expression [7.1, Issue 1, 2022, Pages 15-20]
  • Sara, Elsaadawy The effect of melatonin on apoptosis in hepatocellular carcinoma cell line: An experimental study [3.2, Issue 2, 2019, Pages 75-79]
  • Sarah, Eissa Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy [4.2, Issue 2, 2020, Pages 69-73]
  • Sarkar, Kumkum Outcome of Hepatitis B treatment with oral drugs (Tenofovir and Entecavir) in a tertiary care center in eastern India [8.2, Issue 2, 2024, Pages 17-20]
  • Schaalan, Mona Burden of parasitic infection and its impact on growth of children with hepatitis C Virus [6.1, Issue 1, 2021, Pages 17-23]
  • Schalaan, Mona Gaucher disease: Recent advances in the diagnosis and management. [6.2, Issue 2, 2022, Pages 6-10]
  • Seif, Seham Mini-dose albumin can reduce renal impairment in cirrhotic patients with spontaneous bacterial peritonitis [5.1, Issue 1, 2020, Pages 13-18]
  • Seif, Seham Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]
  • Selim, Mahmoud Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 9-15]
  • Shabana, Hany Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis [8.1, Issue 1, 2024, Pages 1-7]
  • Shabana, Hany Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ? [8.1, Issue 1, 2024, Pages 17-22]
  • Shaband, Nora Castleman disease as an unusual cause of ascites : Case report [6.2, Issue 2, 2022, Pages 1-3]
  • Shehab-Eldeen, Somaia Serum microRNA 106 and microRNA 223 as novel biomarkers in inflammatory bowel disease [5.1, Issue 1, 2020, Pages 19-24]
  • Shehab-Eldeen, Somaia Evaluation of liver stiffness by non-invasive methods after eradication of HCV by direct-acting antiviral therapy: a retrospective observational study [6.3, Issue 3, 2022, Pages 5-11]
  • Sheren, Younes Value of Cytokeratin-18 as a non-invasive diagnostic biomarker of nonalcoholic steatohepatitis (NASH) [3.2, Issue 2, 2019, Pages 65-74]
  • Sheta, Tarek Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients [5.2, Issue 2, 2021, Pages 9-15]
  • Sheta, Tarek Diagnostic utility of absolute neutrophil count as a new marker of spontaneous bacterial peritonitis; multicenter study [6.3, Issue 3, 2022, Pages 12-18]
  • Shiha, Gamal Comparison between transient elastography and other markers for predicting the fibrosis stages of patients with chronic HCV infection in Beni-Suef governorate, Egypt [4.1, Issue 1, 2019, Pages 45-52]
  • Shiha, Gamal Misuse of anticoagulants in COVID-19 patient: A case of gastrointestinal bleeding [5.2, Issue 2, 2021, Pages 1-2]
  • Shiha, Gamal Genetic Variability of NS5B Region of Hepatitis C Virus in Togo [5.3, Issue 3, 2021, Pages 8-13]
  • Shiha, Gamal Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program [7.2, Issue 2, 2023, Pages 9-14]
  • Simpore, Jacques Genetic Variability of NS5B Region of Hepatitis C Virus in Togo [5.3, Issue 3, 2021, Pages 8-13]
  • Simpore, Jacques Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]
  • SM., Seif Hepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B [2.1, Issue 1, 2016, Pages 1-11]
  • Soliman, Gamal The Role of Endoscopic Ultrasound in Patients with Choledocholithiasis: A pilot study [(Articles in Press)]
  • Soliman, R Health-Related Quality of Life after Direct Acting Antiviral Treatment for Chronic Hepatitis C in a community Led Program [7.2, Issue 2, 2023, Pages 9-14]
  • Soliman, Reham Misuse of anticoagulants in COVID-19 patient: A case of gastrointestinal bleeding [5.2, Issue 2, 2021, Pages 1-2]
  • Soliman, Reham Genetic Variability of NS5B Region of Hepatitis C Virus in Togo [5.3, Issue 3, 2021, Pages 8-13]
  • Soliman, Reham Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]
  • Somaia, Shehab-Eldeen Value of Cytokeratin-18 as a non-invasive diagnostic biomarker of nonalcoholic steatohepatitis (NASH) [3.2, Issue 2, 2019, Pages 65-74]
  • Soulier, Alexandre Genetic Variability of NS5B Region of Hepatitis C Virus in Togo [5.3, Issue 3, 2021, Pages 8-13]
  • Sundaram, Sridhar HCV Genotype 5a presenting with hepatocellular cancer: First report from India [5.1, Issue 1, 2020, Pages 1-2]

T

  • Taha, Ahmed Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Taha, Ahmed Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review [5.2, Issue 2, 2021, Pages 3-8]
  • Taha, Khaled Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter study [6.2, Issue 2, 2022, Pages 11-17]
  • Taha, Khaled Incidence and predictors of acute oesophageal variceal haemorrhage in patients with spontaneous bacterial peritonitis [7.1, Issue 1, 2022, Pages 1-7]
  • Taha, Khaled Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Tarek, F. Sheta Evaluation of the causes and outcome of lower gastrointestinal bleeding: An endoscopic study [3.1, Issue 1, 2018, Pages 19-25]
  • Tarek, sheta The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B [3.2, Issue 2, 2019, Pages 57-64]
  • Tarek, Sheta The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Tarik, Zaher Management of chronic hepatitis B in special populations [4.2, Issue 2, 2020, Pages 63-68]
  • Tolba, Amina M. Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model [7.1, Issue 1, 2022, Pages 8-12]
  • Tsevi, Mawufemo C. Seroepidemiology and risk factor of hepatitis B and C virus infections in hemodialysis patients in Lomé, Togo. [5.3, Issue 3, 2021, Pages 22-26]

W

  • W., Samir Seroprevalence of hepatitis A virus infection in patients with chronic liver diseases: Do we need to vaccinate? [1.1, Issue 1, 2015, Pages 1-9]
  • W., Samir Interferon-ë rs12979860CC genotype predicts sustained virological response to therapy in patients with chronic hepatitis C Genotype 4 but enhances hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-12]
  • W., Samir A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-severe and severe fibrosis in patients with chronic Hepatitis C [1.2, Issue 2, 2016, Pages 1-10]
  • W., Samir Transient elastography (FibroScan) is not useful in the diagnosis of schistosomal hepatic fibrosis [1.2, Issue 2, 2016, Pages 1-10]
  • Walaa, Shabana The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis [2.2, Issue 2, 2018, Pages 25-29]
  • Waleed, Eldars Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy [4.2, Issue 2, 2020, Pages 69-73]

Y

  • Yassen, Ahmed Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Yassen, Ahmed Culture negative neutrocytic ascites versus culture positive spontaneous bacterial peritonitis; Is there a Difference; A Multi-Centric Study [5.3, Issue 3, 2021, Pages 1-7]
  • Yassen, Ahmed Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]
  • Yassen, Ahmed Incidence and predictors of acute oesophageal variceal haemorrhage in patients with spontaneous bacterial peritonitis [7.1, Issue 1, 2022, Pages 1-7]
  • Yassen, Ahmed Impact of COVID-19 on mortality rate in patients with chronic liver diseases, single-centre observational study [7.2, Issue 2, 2023, Pages 15-22]

Z

  • Zakaria, Sahar Impact of COVID-19 pandemic on hospital admission for endoscopy unit; single center study [5.1, Issue 1, 2020, Pages 41-45]
  • Zaki, Maysaa ElSayed Role of interferon gamma gene polymorphism in spontaneous viral clearance versus chronicity in hepatitis C infected Egyptian patients [6.1, Issue 1, 2021, Pages 24-31]
  • Zaki, Maysaa Diagnostic value of of Long Non-Coding RNA ZFAS1 as a Potential Biomarker for Hepatocellular Carcinoma [6.2, Issue 2, 2022, Pages 18-24]